125 related articles for article (PubMed ID: 36226349)
21. MAP7 Promotes Breast Cancer Cell Migration and Invasion by Regulating the NF-B Pathway.
Wang R; Xie S; He Y; Zheng R; Zhang M; Jin J; Wang M
Ann Clin Lab Sci; 2022 Sep; 52(5):721-730. PubMed ID: 36261182
[TBL] [Abstract][Full Text] [Related]
22. The role and molecular mechanism of metabolic reprogramming of colorectal cancer by UBR5 through PYK2 regulation of OXPHOS expression study.
Qin R; Huang Y; Yao Y; Wang L; Zhang Z; Huang W; Su Y; Zhang Y; Guan A; Wang H
J Biochem Mol Toxicol; 2023 Aug; 37(8):e23376. PubMed ID: 37098808
[TBL] [Abstract][Full Text] [Related]
23. LncRNA-ATB promotes TGF-β-induced glioma cells invasion through NF-κB and P38/MAPK pathway.
Tang F; Wang H; Chen E; Bian E; Xu Y; Ji X; Yang Z; Hua X; Zhang Y; Zhao B
J Cell Physiol; 2019 Dec; 234(12):23302-23314. PubMed ID: 31140621
[TBL] [Abstract][Full Text] [Related]
24. E3 Ubiquitin Ligase UBR5 Drives the Growth and Metastasis of Triple-Negative Breast Cancer.
Liao L; Song M; Li X; Tang L; Zhang T; Zhang L; Pan Y; Chouchane L; Ma X
Cancer Res; 2017 Apr; 77(8):2090-2101. PubMed ID: 28330927
[TBL] [Abstract][Full Text] [Related]
25. E3 ubiquitin ligase UBR5 promotes pancreatic cancer growth and aerobic glycolysis by downregulating FBP1 via destabilization of C/EBPα.
Chen L; Yuan R; Wen C; Liu T; Feng Q; Deng X; Du Y; Peng X
Oncogene; 2021 Jan; 40(2):262-276. PubMed ID: 33122826
[TBL] [Abstract][Full Text] [Related]
26. Clinicopathological Features and Prognostic Evaluation of UBR5 in Liver Cancer Patients.
Huo Q; Hu J; Hou B; Zhao M; Han X; Du Y; Li Y
Pathol Oncol Res; 2022; 28():1610396. PubMed ID: 36388433
[No Abstract] [Full Text] [Related]
27. Myosin Heavy Chain 10 (MYH10) Gene Silencing Reduces Cell Migration and Invasion in the Glioma Cell Lines U251, T98G, and SHG44 by Inhibiting the Wnt/β-Catenin Pathway.
Wang Y; Yang Q; Cheng Y; Gao M; Kuang L; Wang C
Med Sci Monit; 2018 Dec; 24():9110-9119. PubMed ID: 30552850
[TBL] [Abstract][Full Text] [Related]
28. TGFβ1-induced beta-site APP-cleaving enzyme 2 upregulation promotes tumorigenesis through the NF-κB signalling pathway in human gliomas.
Wang H; Chen Z; Wang S; Gao X; Qian M; Qiu W; Zhang Z; Zhang S; Qi Y; Sun X; Xue H; Guo X; Zhao R; Li G
Mol Oncol; 2020 Feb; 14(2):407-425. PubMed ID: 31856384
[TBL] [Abstract][Full Text] [Related]
29. The lncRNA HOXA11-AS promotes glioma cell growth and metastasis by targeting miR-130a-5p/HMGB2.
Xu CH; Xiao LM; Liu Y; Chen LK; Zheng SY; Zeng EM; Li DH
Eur Rev Med Pharmacol Sci; 2019 Jan; 23(1):241-252. PubMed ID: 30657566
[TBL] [Abstract][Full Text] [Related]
30. MicroRNA-193a-5p exerts a tumor suppressor role in glioblastoma via modulating NOVA1.
Jin L; Li H; Wang J; Lin D; Yin K; Lin L; Lin Z; Lin G; Wang H; Ying X; Wang L; Zhang Y; Teng L
J Cell Biochem; 2019 Apr; 120(4):6188-6197. PubMed ID: 30304561
[TBL] [Abstract][Full Text] [Related]
31. Bone marrow mesenchymal stem cells suppress growth and promote the apoptosis of glioma U251 cells through downregulation of the PI3K/AKT signaling pathway.
Lu L; Chen G; Yang J; Ma Z; Yang Y; Hu Y; Lu Y; Cao Z; Wang Y; Wang X
Biomed Pharmacother; 2019 Apr; 112():108625. PubMed ID: 30784920
[TBL] [Abstract][Full Text] [Related]
32. Pard3 suppresses glioma invasion by regulating RhoA through atypical protein kinase C/NF-κB signaling.
Li J; Xu H; Wang Q; Fu P; Huang T; Anas O; Zhao H; Xiong N
Cancer Med; 2019 May; 8(5):2288-2302. PubMed ID: 30848088
[TBL] [Abstract][Full Text] [Related]
33. IKBKE enhances TMZ-chemoresistance through upregulation of MGMT expression in glioblastoma.
Guo G; Sun Y; Hong R; Xiong J; Lu Y; Liu Y; Lu J; Zhang Z; Guo C; Nan Y; Huang Q
Clin Transl Oncol; 2020 Aug; 22(8):1252-1262. PubMed ID: 31865606
[TBL] [Abstract][Full Text] [Related]
34. UBR5 over-expression contributes to poor prognosis and tamoxifen resistance of ERa+ breast cancer by stabilizing β-catenin.
Yang Y; Zhao J; Mao Y; Lin G; Li F; Jiang Z
Breast Cancer Res Treat; 2020 Dec; 184(3):699-710. PubMed ID: 32914356
[TBL] [Abstract][Full Text] [Related]
35. UBR-box containing protein, UBR5, is over-expressed in human lung adenocarcinoma and is a potential therapeutic target.
Saurabh K; Shah PP; Doll MA; Siskind LJ; Beverly LJ
BMC Cancer; 2020 Aug; 20(1):824. PubMed ID: 32867711
[TBL] [Abstract][Full Text] [Related]
36. The transcription factor USF1 promotes glioma cell invasion and migration by activating lncRNA HAS2-AS1.
Wang J; Gu J; You A; Li J; Zhang Y; Rao G; Ge X; Zhang K; Li J; Liu X; Wang Q; Lin T; Cheng L; Zhu M; Wu X; Wang D
Biosci Rep; 2020 Aug; 40(8):. PubMed ID: 32776110
[TBL] [Abstract][Full Text] [Related]
37. Overexpression of lncRNA IRAIN restrains the progression and Temozolomide resistance of glioma via repressing IGF-1R-PI3K-NF-κB signaling pathway.
Guo A; Fang G; Lin Z; Zheng S; Zhuang Z; Lin R; Lin Y
Histol Histopathol; 2022 Jun; 37(6):543-554. PubMed ID: 35102541
[TBL] [Abstract][Full Text] [Related]
38. Hypoxia induced ferritin light chain (FTL) promoted epithelia mesenchymal transition and chemoresistance of glioma.
Liu J; Gao L; Zhan N; Xu P; Yang J; Yuan F; Xu Y; Cai Q; Geng R; Chen Q
J Exp Clin Cancer Res; 2020 Jul; 39(1):137. PubMed ID: 32677981
[TBL] [Abstract][Full Text] [Related]
39. miRNA-429 Inhibits Astrocytoma Proliferation and Invasion by Targeting BMI1.
Peng G; Liao Y; Shen C
Pathol Oncol Res; 2017 Apr; 23(2):369-376. PubMed ID: 27663885
[TBL] [Abstract][Full Text] [Related]
40. FBW7 is associated with prognosis, inhibits malignancies and enhances temozolomide sensitivity in glioblastoma cells.
Lin J; Ji A; Qiu G; Feng H; Li J; Li S; Zou Y; Cui Y; Song C; He H; Lu Y
Cancer Sci; 2018 Apr; 109(4):1001-1011. PubMed ID: 29427543
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
